Martyn Jacobs
Stock Analyst at Bell Potter
(0.04)
# 4,411
Out of 4,429 analysts
174
Total ratings
15.4%
Success rate
-20.7%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.77 → $0.75 | $0.71 | +5.63% | 7 | Jun 14, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $1.87 → $2.00 | $0.38 | +426.32% | 17 | Jun 5, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Buy | $28.75 | $20.05 | +43.39% | 5 | Jun 3, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.80 | $1.98 | +91.92% | 7 | Jun 3, 2026 | |
| ASX: BIO Biome Australia Limited | Maintained: Buy | $1.00 | $0.265 | +277.36% | 17 | Jun 3, 2026 | |
| ASX: AHC Austco Healthcare Limited | Maintained: Buy | $0.55 → $0.45 | $0.23 | +95.65% | 4 | Jun 1, 2026 | |
| ASX: AYA Artrya Limited | Maintained: Buy | $6.10 | $4.79 | +27.35% | 3 | Jun 1, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Maintained: Buy | $1.05 → $0.75 | $0.265 | +183.02% | 15 | May 27, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Maintained: Buy | $3.15 | $1.59 | +98.11% | 8 | May 11, 2026 | |
| ASX: IPD ImpediMed Limited | Maintained: Buy | $0.03 → $0.01 | $0.006 | +66.67% | 14 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $3.00 | $2.82 | +6.38% | 9 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.45 | $0.17 | +164.71% | 9 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.85 | $0.415 | +104.82% | 14 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.34 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.012 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.31 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.07 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.02 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.105 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.037 | n/a | 2 | Oct 31, 2022 |
Monash IVF Group Limited
Jun 14, 2026
Maintained: Hold
Price Target: $0.77 → $0.75
Current: $0.71
Upside: +5.63%
EBR Systems, Inc.
Jun 5, 2026
Maintained: Buy
Price Target: $1.87 → $2.00
Current: $0.38
Upside: +426.32%
Sonic Healthcare Limited
Jun 3, 2026
Maintained: Buy
Price Target: $28.75
Current: $20.05
Upside: +43.39%
Integral Diagnostics Limited
Jun 3, 2026
Maintained: Buy
Price Target: $3.80
Current: $1.98
Upside: +91.92%
Biome Australia Limited
Jun 3, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.265
Upside: +277.36%
Austco Healthcare Limited
Jun 1, 2026
Maintained: Buy
Price Target: $0.55 → $0.45
Current: $0.23
Upside: +95.65%
Artrya Limited
Jun 1, 2026
Maintained: Buy
Price Target: $6.10
Current: $4.79
Upside: +27.35%
Trajan Group Holdings Limited
May 27, 2026
Maintained: Buy
Price Target: $1.05 → $0.75
Current: $0.265
Upside: +183.02%
EMVision Medical Devices Ltd
May 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $1.59
Upside: +98.11%
ImpediMed Limited
May 10, 2026
Maintained: Buy
Price Target: $0.03 → $0.01
Current: $0.006
Upside: +66.67%
Apr 29, 2026
Maintained: Buy
Price Target: $2.25 → $3.00
Current: $2.82
Upside: +6.38%
Apr 27, 2026
Maintained: Buy
Price Target: $0.45
Current: $0.17
Upside: +164.71%
Apr 27, 2026
Maintained: Buy
Price Target: $0.85
Current: $0.415
Upside: +104.82%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.012
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.31
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.07
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.02
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.105
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.037
Upside: n/a